REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Hugel, Inc. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Hugel, Inc. Profile Updated: February 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Hugel, Inc. is engaged in manufacturing pharmaceutical products including Botulinum Toxin, Hyaluronic Acid Filler, and Cosmetic products. The company is based in Chuncheon-si, Gangwon-do Province, South Korea. Hugel, Inc. was incorporated in 2001 as Hugel Co., Ltd.

Headquarters
61-20, Sinbuk-Ro, Sinbuk-Eup
Chuncheon; Gangwon; Postal Code: 24206

Contact Details: Purchase the Hugel, Inc. report to view the information.

Website: http://www.hugel.co.kr

Basic Information
Total Employees:
Purchase the Hugel, Inc. report to view the information.
Outstanding Shares:
Purchase the Hugel, Inc. report to view the information.
Registered Capital:
Purchase the Hugel, Inc. report to view the information.
Financial Auditors:
Purchase the Hugel, Inc. report to view the information.
Incorporation Date:
November 22, 2001
Key Executives
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
22.6%
Purchase this report to view the information.
18.4%
Purchase this report to view the information.
5%
Subsidiaries
Hugel Pharma(Vietnam) Co Ltd
100%
Weihai Hugelpharma Co Ltd
100%
Croma Aesthetics Canada
70%
Company Performance
Financial values in the chart are available after Hugel, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
13.5%▲
Total operating revenue
19.09%▲
Operating profit (EBIT)
43.1%▲
EBITDA
27.6%▲
Net Profit (Loss) for the Period
75.11%▲
Total assets
-11.48%▼
Total equity
-8.21%▼
Operating Profit Margin (ROS)
8.79%▲
Net Profit Margin
12.17%▲
Return on Equity (ROE)
6.75%▲
Debt to Equity Ratio
-0.46%▼
Quick Ratio
5.96%▲
Cash Ratio
1.1%▲

Similar companies

Cj Cheiljedang Corporation
 
SK Discovery Co.,Ltd.
Kt&G Corporation
 
Amore Pacific Group
Samsung Biologics Co., Ltd.
 
Green Cross Holdings Corporation
NutriBiotech Co., Ltd.
 
Glaxo Smithkline Korea Co.,Ltd.
St Pharm Co., Ltd.
 
Samjin Pharmaceutical Co.,Ltd.
Pharma Research Products Co.,Ltd.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo